Standard Operating Procedure for Active Ingredient Penetration Testing in Transdermal Patches
1) Purpose
To establish procedures for testing the penetration of active ingredients through the skin in transdermal patches to ensure efficacy and compliance with product specifications.
2) Scope
This SOP applies to the quality control department responsible for conducting active ingredient penetration testing during transdermal patch manufacturing.
3) Responsibilities
3.1 Quality Control Analyst: Perform penetration testing according to defined procedures.
3.2 Production Supervisor: Provide samples for testing in accordance with sampling plans.
3.3 QA Personnel: Review and approve testing procedures and results.
3.4 Research and Development: Provide support in developing and validating penetration testing methods.
4) Procedure
4.1 Sample Preparation:
4.1.1 Cut transdermal patches into appropriate sections or units for testing.
4.1.2 Ensure samples are identified with batch information and sampling details.
4.2 Testing Method:
4.2.1 Place transdermal patch samples on skin membrane models or suitable biological membranes.
4.2.2 Apply testing conditions such as temperature, humidity, and exposure time as per protocol.
4.3 Analysis of Penetration:
4.3.1 Collect samples after specified exposure periods and remove excess formulation.
4.3.2 Analyze
4.4 Data Interpretation:
4.4.1 Calculate penetration rates and compare against acceptance criteria or specifications.
4.4.2 Record observations and deviations from expected results, if any.
4.5 Reporting:
4.5.1 Document testing procedures, results, and conclusions in designated test records or laboratory notebooks.
4.5.2 Prepare test reports summarizing penetration testing outcomes and compliance with specifications.
4.6 Documentation:
4.6.1 Maintain detailed records of penetration testing activities, including raw data and calculations.
4.6.2 Archive test reports and related documentation for review and audits as per document control procedures.
5) Abbreviations, if any
SOP: Standard Operating Procedure
QA: Quality Assurance
R&D: Research and Development
6) Documents, if any
Penetration Testing Protocols
Test Reports
Batch Production Records
7) Reference, if any
USP General Chapter 1724: Performance Tests on Transdermal Drug Delivery Systems
ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products
8) SOP Version
Version 1.0
